fbpx

Sydney, Australia, and Utrecht, the Netherlands, August 31st, 2018

MILabs announces that it has successfully completed the installation of its next-generation Adaptive U-CTXUHR at Sydney Imaging, a Core Research Facility of the University of Sydney. Recognizing that excellence in research is increasingly linked to excellence in infrastructure capability, Sydney Imaging selected MILabs X-ray CT system for its unprecedented dose-efficiency for in vivo imaging of a wide variety of in vivo animal models of human diseases, from mice to rabbits.  The system offers a unique combination of very low-dose, fast and high-resolution diagnostic X-ray CT and can, at any time, be upgraded to molecular CT imaging.

Prof. Fernando Calamante, Director of Sydney Imaging explained, “This new Adaptive CT system represents a significant contribution to our expanding set of biomedical imaging equipment at Sydney Imaging, and provides a powerful complementary tool to drive innovation and translational research. It reflects the University’s long-term strategic plan of providing state-of-the-art research infrastructure, as platforms for collaboration.”

Prof. F. Beekman, CEO/CSO MILabs B.V. added: “We are delighted to add Sydney Imaging to our fast growing user-base of Adaptive CT systems. We are looking forward to work with this core biomedical imaging facility to further accelerate its research programs, and to further adapt the system for molecular imaging applications if the need develops”.

Trent Warburton,  Managing Director at TrendBio, MILabs’ exclusive Australian distributor,  stated, “We are particularly pleased to be able to provide the MILabs advanced preclinical imaging technologies to the Australian scientific community and in particular into a core research facility at the University of Sydney”.

MILabs Adaptive CT combines cutting-edge CMOS technology with a thick scintillation layer to efficiently convert low-dose X-rays to CT images. With dual-gating capabilities and on-the-fly readout, the system sets new low-dose benchmarks without compromising image quality for all in-vivo CT imaging applications.

About:

Sydney Imaging, University of Sydney offers world-class imaging capabilities and academic expertise. Sydney Imaging is a unique facility for research and education in the field of biomedical science and offers preclinical and clinical modalities, and a world-class hybrid theatre providing the capability for translational research along with training and development of specialized imaging skills. Sydney Imaging is located at the University of Sydney’s Charles Perkins Centre and Brain and Mind Centre. For more information, visit: https://sydney.edu.au/research/facilities/sydney-imaging.html

TrendBio (Melbourne, Australia) is a specialized instrument and consumable supplier servicing the Australian and New Zealand scientific markets. With products from market leaders across the divisions of Imaging, Genomics, Proteomics, Cell Biology, Biologics, and Chemistry. As a leading supplier, TrendBio provides high-level support covering technical, applications and sales. For more information, visit https://www.trendbio.com.au

MILabs B.V. (Utrecht, the Netherlands) provides high-end integrated multimodality imaging solutions for biomedical and pharmaceutical research, designed to deliver high-definition molecular, functional and anatomical images. Today these systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases. For more information, visit  www.milabs.com or contact MILabs at [email protected]

Share on social media
Share on facebook
Share on twitter
Share on linkedin
Share on email

Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands – Prof. Harrie Weinans & Dr. Bart van der Wal

  – Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands –  – Prof. …

Read More →

Press Release: MILABS launches its 7th generation of preclinical imagers at the World Molecular Imaging Conference 2021

Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value …

Read More →

Press Release: RIGAKU Acquires Life Science Imaging Equipment Manufacturer MILabs

August 3, 2021 – Houten, the Netherlands Dear readers, We are very excited that MILabs …

Read More →

Press Release: Confocal PET Causes Spectral PET Breakthrough in Preclinical Imaging

Houten, the Netherlands – March 24, 2021 Using its unique Confocal PET technology, MILabs B.V …

Read More →

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University – Bridging the “valley of death” …

Read More →

Spotlight on Bart Cornelissen, PhD – Department of Oncology, Oxford Institute for Radiation Oncology at University of Oxford

– Targeting Tumors from the inside –   Dr. Bart Cornelissen is Group Leader and …

Read More →

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of …

Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a …

Read More →

MILabs announced the co-winners of the 2020 MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress …

Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor …

Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting …

Read More →

The University of Southampton enters the field of Correlative In-Vivo Imaging by Acquiring MILabs 3D/4D Optical/CT

May 12, 2020, Southampton, UK – Utrecht, the Netherlands The Faculty of Medicine, University of …

Read More →
Scroll to Top